What to Give Your Friend Diagnosed with Cancer

When a friend is diagnosed with cancer it is not easy to know what to say or how to express support. Simply being present and checking in to ask how they are doing and listening are sometimes all they need to know you are there for them. Many people want to give a...

FDA Approves First Therapy Specific for RET-Driven Lung and Thyroid Cancers

Lilly's Retevmo® (selpercatinib, 40 mg & 80 mg capsules) is approved by the U.S. Food and Drug Administration (FDA) as the first therapy for patients with specific lung cancer and the treatment of patients with specific thyroid cancers. According to Lilly, the...

The Plate Method for Managing Diabetes and Other Inflammatory Diseases

For people living with diabetes and their families, following a special diet may seem tedious. The American Diabetes Association has an interesting article that makes following a low glycemic diet so much easier. Skip weighing and calculating your food by learning...

Positive Topline Results for Patients with Heart Disease

Bristol Myers Squibb's mavacamten delivers positive topline results from Phase III VALOR-HCM in adults with symptomatic obstructive hypertrophic cardiomyopathy (obstructive HCM) who are eligible for septal reduction therapy (SRT) and have been referred for an invasive...

Great News for High-Risk Breast Cancer Patients

Great news for high-risk breast cancer patients who have early stage or advanced metastasized cancer. Lynparza is the first PARP inhibitor drug specifically approved as treatment for BRCA- mutated breast cancer. AstraZeneca and Merck's Lynparza (olaparib) is approved...
Green Light for Rinvoq to Treat Atopic Dermatitis Among Others

Green Light for Rinvoq to Treat Atopic Dermatitis Among Others

Good news for people age 12 and up that suffer from the endless cycle of itching and scratching that comes with moderate to severe atopic dermatitis. Upadacitinib, a selective and reversible JAK inhibitor was discovered and developed by AbbVie. The milestone marks the...

inflammation guide logo

You have Successfully Subscribed!